Archive for the 'Alzheimers Disease' Category
Allon’s Phase 1 Trial Broadens Davunetide’s Intranasal Safety And Dose Range
Allon Therapeutics Inc. (TSX:NPC) announced today that a Phase 1 clinical trial of its lead neuroprotective drug, davunetide , which began patient enrolment January 28, 2010, has been completed. The results demonstrated that the intranasal dose range can be broadened and provided additional information on the pharmacokinetic profile of davunetide…Original post by Allergy News From Medical News Today
No commentsPoliticians Not Doing Enough To Improve Care For Older People, UK
Sixty per cent of people think politicians are not doing enough to improve care for older people according to a survey by Age Concern and Help the Aged. The poll also found that eight out of ten adults believe care reform is among the most important issues in the forthcoming election…Original post by Allergy News From Medical News Today
No commentsNew Evidence Further Validates Ketone Body Therapy As An Effective Approach In Managing Alzheimer’s Disease
Accera, Inc., a biotechnology company delivering breakthrough therapies in central nervous system diseases, announced data which showed that augmentation with ketone bodies significantly improved cognitive function in Alzheimer’s disease (AD) patients. An early feature of AD is region specific declines in cerebral glucose metabolism…Original post by Allergy News From Medical News Today
No commentsState Roundup: N.Y. Drug Pricing, Vermont Hospital Ads, Massachusetts Nursing Homes And Anti-Psychotics
Poughkeepsie Journal: A new report on New York drug prices, “issued by the New York Public Interest Research Group, Consumers Union, the Center for Medical Consumers and AARP, looked at the price of the 10 most popular drugs found in the state’s pharmacies provided through a Freedom of Information Law request…Original post by Allergy News From Medical News Today
No commentsAlzheimer’s Association Honors Social Security Commissioner Michael Astrue With Humanitarian Award
Social Security Commissioner Michael Astrue is the recipient of the Alzheimer’s Association’s 2010 Humanitarian Award. The award is given each year to a public official who has made a significant contribution to help those who are struggling with Alzheimer’s disease…Original post by Allergy News From Medical News Today
No commentsAfrican-Americans And Hispanics More Likely To Have Alzheimer’s Disease And Dementia Than Whites
According to the Alzheimer’s Association’s® 2010 Alzheimer’s Disease Facts and Figures, African-Americans are about two times more likely and Hispanics are about one and one-half times more likely than their white counterparts to have Alzheimer’s and other dementias…Original post by Allergy News From Medical News Today
No commentsHas The Clock Struck 12 For Dimebon?
The Cinderella story eventually has a happy ending, but to revelers in the Dimebon story right now the time must feel like five past midnight. Some scientists have considered the sudden transformation of a modest hay fever medicine from Russia into the latest star in the AD drug development arena as a bit of a fairy tale all along…Original post by Allergy News From Medical News Today
No commentsTechnology And Positive Attitudes Improving Older People’s Lives
The population of the UK is ageing. Sixteen per cent of the UK population is 65 or older, and for the first time, there are more people over the age of 65 than there are under the age of 18. This raises a lot of questions on issues such as pension provision, health care and wellbeing…Original post by Allergy News From Medical News Today
No commentsMajor Depression More Than Doubles Risk Of Dementia Among Adults With Diabetes
Adults who have both diabetes and major depression are more than twice as likely to develop dementia, compared to adults with diabetes only, according to a study published in the recent Journal of General Internal Medicine. Dementia is the progressive decline of thinking and reasoning abilities…Original post by Allergy News From Medical News Today
No commentsAlzforum’s 5-Part Series On Alzheimer’s Prevention Initiative
The field is abuzz with the word “prevention,” but how to pull off this vaunted goal? It’s been held back by a strange Catch-22 of cost, time, and biomarker validation. That might change with a bold initiative led by Eric Reiman, Pierre Tariot, and others at the Banner Alzheimer’s Institute…Original post by Allergy News From Medical News Today
No comments